$A News

Deutsche Bank Initiates Coverage of Agilent Technologies at Buy

Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow

$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today

Agilent acquires Proscia in deal worth up to $270m

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist

Agilent to buy Proscia for $240M

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196

Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?

Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?

Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195

$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story

Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue?

If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now

Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation

Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript